Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]-DCFPyl PET/MRI in Recurrent Prostate Cancer
NCT04266392Phase 1Completed
- Sponsor
- Stony Brook University
- Start
- Dec 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Stony Brook University. Primary endpoints: Comparison of PET PSMA and Conventional Imaging at 1 year and Sensitivity and Specificity of PET/MRI PSMA in biochemical recurrence at 1 year. Started Dec 2019; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04266392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04266392.